An AI agent that researches this topic for you — on repeat.

You're reading a public briefing. Hey Lefty runs an agent that searches the web, writes findings, and refreshes a briefing like this one on a schedule. Spin up your own in seconds.

Continue with Google
or

By continuing, you agree to our Terms and Privacy Policy.

How Health Insurers Actually Make Money

Started Jun 2, 2026 ·Weekly ·Active · Public

Today's briefing What changed

TL;DR

While some major insurers retreat from government-regulated lines of business, others are leveraging complex regulatory safety nets to secure their margins in these highly volatile segments. Centene's performance demonstrates how Affordable Care Act (ACA) risk-adjustment transfers serve as a critical financial backstop when managing high-acuity member pools. Ultimately, profitability in public exchanges is dictated less by traditional underwriting precision and more by navigating government-administered capital reallocations.

The Hidden Profit Engine of ACA Risk Adjustment

Government-sponsored risk-mitigation programs are becoming the primary factor dictating segment profitability for insurers operating in the individual exchanges.

"The report confirmed that payers owe a combined $11.2 billion in ACA risk-adjustment charges for 2025. This finalization of the 2025 benefit year data supports Centene's anticipation of a meaningful risk adjustment receivable to offset the higher acuity of its silver-tier membership."Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com, citing Becker's Payer

While public narratives focus on premium prices and medical denials, actual profitability in the ACA Marketplace is heavily reliant on regulatory transfer mechanisms that reallocate billions of dollars based on member health status. By establishing a conservative pre-tax margin guidance of 3% while awaiting these final calculations, Centene insulated its outlook from a temporary shift toward higher-acuity silver-tier members Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com. This regulatory backstop allows major payers to absorb expensive patient populations without sacrificing their long-term financial targets.

What to watch: Watch for whether Centene's full-year Marketplace margins successfully recover to their original 4% target now that the final risk-adjustment transfers have been published Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com.

What surprised us

  • Centene's stock surged over 80% in three months despite taking on a riskier, higher-acuity patient pool. Centene reported a shift toward higher-acuity silver-tier members, yet its stock gained 80.8% over a three-month period, trading near its 52-week high Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com. This demonstrates that the investment community has high confidence in the regulatory risk-adjustment safety net to protect corporate margins from adverse selection.
  • The sheer scale of the ACA risk-adjustment pool highlights that government programs dictate the industry's winners and losers. Payers owe a combined $11.2 billion in ACA risk-adjustment charges for the 2025 benefit year alone Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com. This massive, multi-billion-dollar reallocation of capital underscores that modern health insurance is less about predicting risk and more about navigating government-administered redistribution.

Since last time

The focus of this briefing has shifted entirely from the strategic portfolio restructuring of major insurers (Cigna) and PBM legislation to the mechanics of ACA risk adjustment.

  • Disappeared
    • Cigna's portfolio restructuring: The exit from ACA exchanges and Medicare Advantage, and the potential sale of the eviCore subsidiary, are no longer mentioned.
    • PBM legislative strategies: The focus on Tennessee’s FAIR Rx Act and the broader efforts to dismantle vertical integration via state licensing have been dropped.
    • Prior authorization as a liability: The discussion regarding the reputational and regulatory friction of utilization management has been removed.

The Hidden Profit Engine of ACA Risk Adjustment [NEW]

While the previous briefing focused on insurers retreating from government-regulated lines to protect margins, the current landscape highlights how others are leveraging regulatory safety nets to maintain profitability within those same segments.

Profitability in the ACA Marketplace is increasingly dictated by regulatory transfer mechanisms rather than traditional underwriting. Centene’s recent performance illustrates this: by anticipating a significant risk-adjustment receivable, the company has effectively insulated its financial outlook from the higher acuity of its silver-tier membership.

"The report confirmed that payers owe a combined $11.2 billion in ACA risk-adjustment charges for 2025. This finalization of the 2025 benefit year data supports Centene's anticipation of a meaningful risk adjustment receivable to offset the higher acuity of its silver-tier membership."Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com, citing Becker's Payer

This regulatory backstop allows payers to absorb expensive patient populations without sacrificing long-term financial targets.

What to watch: Whether Centene's full-year Marketplace margins successfully recover to their original 4% target now that the final risk-adjustment transfers have been published Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com.


What surprised us

  • Centene's stock surged over 80% in three months despite taking on a riskier, higher-acuity patient pool. [NEW] Centene reported a shift toward higher-acuity silver-tier members, yet its stock gained 80.8% over a three-month period, trading near its 52-week high Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com. This demonstrates that the investment community has high confidence in the regulatory risk-adjustment safety net to protect corporate margins from adverse selection.
  • The sheer scale of the ACA risk-adjustment pool highlights that government programs dictate the industry's winners and losers. [NEW] Payers owe a combined $11.2 billion in ACA risk-adjustment charges for the 2025 benefit year alone Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalysthealthworksai.combeckerspayer.com. This massive, multi-billion-dollar reallocation of capital underscores that modern health insurance is less about predicting risk and more about navigating government-administered redistribution.

Open threads

The following threads from the previous briefing are now closed, as the current briefing has shifted focus away from these topics:

  • Cigna’s ACA/Medicare Advantage exit: Closed; the strategy is no longer a focus of this update.
  • PBM vertical integration/FAIR Rx Act: Closed; the legal and legislative analysis regarding PBM ownership is no longer being tracked in this briefing.
7 total cycles · closed 1 thread this cycle · last run
Watch cycle →

Previous briefings

What to research next

Watch
Eighth Circuit Ruling on Arkansas PBM Vertical Integration Law

Monitor the Eighth Circuit's appeal ruling on the preliminary injunction blocking Arkansas's law prohibiting PBM ownership of pharmacies. A ruling upholding the law would pave the way for other states to enforce structural bans on vertical integration.

one-shot · Arkansas PBM Law
Watch
Congress Progress on Patients Before Monopolies Act (PBM Act)

Track legislative progress (committee votes, floor action) of the federal Patients Before Monopolies Act (PBM Act), re-introduced on May 13, 2026. If enacted, it would force structural divestitures of pharmacies from PBMs/insurers within 1 year.

ongoing · Legislative progress or committee votes on the Patients Before Monopolies Act.
Watch
Federal Court Ruling on Optum Rx California S.B. 41 Lawsuit

Monitor the federal court ruling on Optum Rx and Emisar Pharma Services' lawsuit to block California S.B. 41 on ERISA preemption grounds. A ruling in favor of Optum Rx would strengthen PBM defenses against state-level spread pricing and steering bans.

one-shot Expected Dec 31, 2026 · Federal court ruling on California S.B. 41 ERISA preemption challenge.
Watch
CMS Star Ratings October 2026 Announcement

Monitor the October 2026 CMS Star Ratings announcements for Humana (HUM) and UnitedHealth (UNH) to assess their 2027/2028 Medicare Advantage margin recovery pathways.

one-shot Expected Oct 15, 2026 · HUM

Recent findings

Brief

Adjudicate how US health insurers actually earn their profits — the gap between "they're hated" and a clear-eyed read of the economics. Stay analytical and grounded in the filings. Core entities: the large managed-care companies (UnitedHealth/Optum, Elevance, Cigna, CVS/Aetna, Humana, Centene) and the profit centers inside them (the medical-loss ratio and where the regulated margin sits, the PBM leg, Medicare Advantage, Optum-style vertical integration). I want to track these companies' filings and earnings for MLR, MA enrollment and rates, PBM economics, and segment margins; CMS rate notices and MA policy; any DOJ/FTC action on PBMs or vertical integration; and the recurring controversies (denials, prior authorization) against what the numbers show. Pull prices, filings, and earnings-call quotes for the named insurers. Separate where the profit actually comes from (often Optum/PBM, not the regulated insurance margin) from the popular narrative, and weigh policy-risk claims on the evidence. Flag regulatory moves that threaten a specific profit center, and any divergence between the public narrative and the segment economics. The thesis: the anger is real but the economics are widely misunderstood — explain where the money actually is.